Showing results (401-410 of 516) with videos related to

Sort By:
Pageof 52
Neurophysiologie Clinique = Clinical Neurophysiology|March 15, 2006
Electrophysiological characteristics of limbic and motor globus pallidus internus (GPI) neurons in two cases of Lesch-Nyhan syndromeE Pralong, C Pollo, P Coubes, et al.
Journal of Cell Science|August 27, 1998
The vitronectin receptor associates with clathrin-coated membrane domains via the cytoplasmic domain of its beta5 subunitP G De Deyne, A O'Neill, W G Resneck, et al.
The Journal of General Physiology|May 14, 2026
Dysferlin's C2A domain supports normal Ca2+ signaling and membrane repair in dysferlin-null myofibersValeriy Lukyanenko, Joaquin Muriel, Kassidy K Banford, et al.
Hepatology (Baltimore, Md.)|January 1, 1984
The effect of bile duct obstruction on the clearance of circulating IgA immune complexesP R Harmatz, R E Kleinman, B W Bunnell, et al.
Pediatric Research|June 1, 1983
Passive transplacental immunization: influence on the detection of enteric antigen in the systemic circulationR E Kleinman, P R Harmatz, L A Jacobson, et al.
The Journal of Clinical Investigation|September 1, 1972
An evaluation of antibodies and clinical resistance to salmon calcitoninF R Singer, J P Aldred, R M Neer, et al.
Journal of the American Chemical Society|February 1, 2007
High-capacity hydrogen and nitric oxide adsorption and storage in a metal-organic frameworkBo Xiao, Paul S Wheatley, Xuebo Zhao, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1974
Transformation by simian virus 40 of spleen cells from a hyperimmune rabbit: demonstration of production of specific antibody to the immunizing antigenA D Strosberg, J J Collins, P H Black, et al.
Brain Research|May 30, 1998
Effects of testosterone and progesterone on brain 5alpha-reductase and aromatase in Long-Evans males and comparison of aromatase in Long-Evans vs. Sprague-Dawley ratsE D Lephart, P C Butler, R H Mills, et al.
European Journal of Cancer (Oxford, England : 1990)|December 13, 2005
A study from the EORTC new drug development group: open label phase II study of sabarubicin (MEN-10755) in patients with progressive hormone refractory prostate cancerW Fiedler, N Tchen, J Bloch, et al.
Pageof 52